![QBL QBL](https://data.pdbj.org/pdbjplus/data/cc/svg/QBL.svg) | QBL | Name: | 1-({(7M)-7-[1-(azetidin-3-yl)-6-chloro-1,2,3,4-tetrahydroquinolin-8-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione | Formula: | C24 H23 Cl N4 O2 S | SMILES: | Clc1cc(c2ccnc3cc(CN4C(=O)CCC4=O)sc23)c2c(c1)CCCN2C1CNC1 | InChi: | InChI=1S/C24H23ClN4O2S/c25-15-8-14-2-1-7-28(16-11-26-12-16)23(14)19(9-15)18-5-6-27-20-10-17(32-24(18)20)13-29-21(30)3-4-22(29)31/h5-6,8-10,16,26H,1-4,7,11-13H2 | Definition date: | 2022-06-06 | Last modified: | 2023-09-15 | Release date: | 2023-09-20 | Identifier: | 1-({(7M)-7-[1-(azetidin-3-yl)-6-chloro-1,2,3,4-tetrahydroquinolin-8-yl]thieno[3,2-b]pyridin-2-yl}methyl)pyrrolidine-2,5-dione |
|
![IUD IUD](https://data.pdbj.org/pdbjplus/data/cc/svg/IUD.svg) | IUD | Name: | Paltusotine | Formula: | C27 H22 F2 N4 O | SMILES: | NC1CCN(CC1)c2c(cnc3ccc(cc23)c4cccc(C#N)c4O)c5cc(F)cc(F)c5 | InChi: | InChI=1S/C27H22F2N4O/c28-19-10-18(11-20(29)13-19)24-15-32-25-5-4-16(22-3-1-2-17(14-30)27(22)34)12-23(25)26(24)33-8-6-21(31)7-9-33/h1-5,10-13,15,21,34H,6-9,31H2 | Synonyms: | 3-[4-(4-azanylpiperidin-1-yl)-3-[3,5-bis(fluoranyl)phenyl]quinolin-6-yl]-2-oxidanyl-benzenecarbonitrile | Definition date: | 2022-07-14 | Last modified: | 2023-09-15 | Release date: | 2023-04-19 | Identifier: | 3-[4-(4-azanylpiperidin-1-yl)-3-[3,5-bis(fluoranyl)phenyl]quinolin-6-yl]-2-oxidanyl-benzenecarbonitrile |
|
![IVB IVB](https://data.pdbj.org/pdbjplus/data/cc/svg/IVB.svg) | IVB | Name: | nalfurafine | Formula: | C28 H32 N2 O5 | SMILES: | CN([CH]1CC[C]2(O)[CH]3Cc4ccc(O)c5O[CH]1[C]2(CCN3CC6CC6)c45)C(=O)C=Cc7cocc7 | InChi: | InChI=1S/C28H32N2O5/c1-29(23(32)7-4-18-9-13-34-16-18)20-8-10-28(33)22-14-19-5-6-21(31)25-24(19)27(28,26(20)35-25)11-12-30(22)15-17-2-3-17/h4-7,9,13,16-17,20,22,26,31,33H,2-3,8,10-12,14-15H2,1H3/b7-4+/t20-,22-,26+,27+,28-/m1/s1 | Synonyms: | ~{N}-[(4~{R},4~{a}~{S},7~{R},7~{a}~{R},12~{b}~{S})-3-(cyclopropylmethyl)-4~{a},9-bis(oxidanyl)-1,2,4,5,6,7,7~{a},13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-~{N}-methyl-propanamide | Definition date: | 2022-07-19 | Last modified: | 2023-09-15 | Release date: | 2023-04-12 | Identifier: | (~{E})-~{N}-[(4~{R},4~{a}~{S},7~{R},7~{a}~{R},12~{b}~{S})-3-(cyclopropylmethyl)-4~{a},9-bis(oxidanyl)-1,2,4,5,6,7,7~{a},13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-~{N}-methyl-prop-2-enamide |
|
![RQB RQB](https://data.pdbj.org/pdbjplus/data/cc/svg/RQB.svg) | RQB | Name: | (3S,5S,8aS)-3-[(1-methyl-1H-indol-3-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | Formula: | C17 H19 N3 O2 | SMILES: | Cn1cc(CC2NC(=O)C3CCCN3C2=O)c2ccccc21 | InChi: | InChI=1S/C17H19N3O2/c1-19-10-11(12-5-2-3-6-14(12)19)9-13-17(22)20-8-4-7-15(20)16(21)18-13/h2-3,5-6,10,13,15H,4,7-9H2,1H3,(H,18,21)/t13-,15-/m0/s1 | Definition date: | 2023-08-22 | Last modified: | 2023-09-15 | Release date: | 2023-09-20 | Identifier: | (3S,5S,8aS)-3-[(1-methyl-1H-indol-3-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
|
![XNO XNO](https://data.pdbj.org/pdbjplus/data/cc/svg/XNO.svg) | XNO | Name: | xanomeline | Formula: | C14 H23 N3 O S | SMILES: | CN1CCC=C(C1)c1nsnc1OCCCCCC | InChi: | InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3 | Synonyms: | (5M)-5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine | Definition date: | 2023-02-03 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | (5M)-5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine |
|
![T9C T9C](https://data.pdbj.org/pdbjplus/data/cc/svg/T9C.svg) | T9C | Name: | (S)-4'-hydroxy-3'-(6-methyl-2-oxo-3-(1H-pyrazol-4-yl)indolin-3-yl)-[1,1'-biphenyl]-2,4-dicarboxylic acid | Formula: | C26 H19 N3 O6 | SMILES: | Cc1ccc2c(NC(=O)[C]2(c3c[nH]nc3)c4cc(ccc4O)c5ccc(cc5C(O)=O)C(O)=O)c1 | InChi: | InChI=1S/C26H19N3O6/c1-13-2-6-19-21(8-13)29-25(35)26(19,16-11-27-28-12-16)20-10-14(4-7-22(20)30)17-5-3-15(23(31)32)9-18(17)24(33)34/h2-12,30H,1H3,(H,27,28)(H,29,35)(H,31,32)(H,33,34)/t26-/m1/s1 | Synonyms: | 4-[3-[(3S)-6-methyl-2-oxidanylidene-3-(1H-pyrazol-4-yl)-1H-indol-3-yl]-4-oxidanyl-phenyl]benzene-1,3-dicarboxylic acid | Definition date: | 2023-01-04 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | 4-[3-[(3~{S})-6-methyl-2-oxidanylidene-3-(1~{H}-pyrazol-4-yl)-1~{H}-indol-3-yl]-4-oxidanyl-phenyl]benzene-1,3-dicarboxylic acid |
|
![L3N L3N](https://data.pdbj.org/pdbjplus/data/cc/svg/L3N.svg) | L3N | Name: | 1~{H}-quinazoline-2,4-dione | Formula: | C8 H6 N2 O2 | SMILES: | O=C1NC(=O)c2ccccc2N1 | InChi: | InChI=1S/C8H6N2O2/c11-7-5-3-1-2-4-6(5)9-8(12)10-7/h1-4H,(H2,9,10,11,12) | Definition date: | 2022-06-15 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | 1~{H}-quinazoline-2,4-dione |
|
![K9U K9U](https://data.pdbj.org/pdbjplus/data/cc/svg/K9U.svg) | K9U | Name: | (2S)-4-(3,4-dichlorophenyl)-1-[(2-oxidanylidene-1H-quinolin-4-yl)carbonyl]-N-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide | Formula: | C24 H21 Cl2 F3 N4 O3 | SMILES: | FC(F)(F)CCNC(=O)[CH]1CN(CCN1C(=O)C2=CC(=O)Nc3ccccc23)c4ccc(Cl)c(Cl)c4 | InChi: | InChI=1S/C24H21Cl2F3N4O3/c25-17-6-5-14(11-18(17)26)32-9-10-33(20(13-32)22(35)30-8-7-24(27,28)29)23(36)16-12-21(34)31-19-4-2-1-3-15(16)19/h1-6,11-12,20H,7-10,13H2,(H,30,35)(H,31,34)/t20-/m0/s1 | Definition date: | 2022-09-14 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | (2~{S})-4-(3,4-dichlorophenyl)-1-[(2-oxidanylidene-1~{H}-quinolin-4-yl)carbonyl]-~{N}-[3,3,3-tris(fluoranyl)propyl]piperazine-2-carboxamide |
|
![KAE KAE](https://data.pdbj.org/pdbjplus/data/cc/svg/KAE.svg) | KAE | Name: | 4-[(2~{S})-4-(3,4-dichlorophenyl)-2-(morpholin-4-ylmethyl)piperazin-1-yl]carbonyl-1~{H}-quinolin-2-one | Formula: | C25 H26 Cl2 N4 O3 | SMILES: | Clc1ccc(cc1Cl)N2CCN([CH](CN3CCOCC3)C2)C(=O)C4=CC(=O)Nc5ccccc45 | InChi: | InChI=1S/C25H26Cl2N4O3/c26-21-6-5-17(13-22(21)27)30-7-8-31(18(16-30)15-29-9-11-34-12-10-29)25(33)20-14-24(32)28-23-4-2-1-3-19(20)23/h1-6,13-14,18H,7-12,15-16H2,(H,28,32)/t18-/m0/s1 | Definition date: | 2022-09-14 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | 4-[(2~{S})-4-(3,4-dichlorophenyl)-2-(morpholin-4-ylmethyl)piperazin-1-yl]carbonyl-1~{H}-quinolin-2-one |
|
![7U5 7U5](https://data.pdbj.org/pdbjplus/data/cc/svg/7U5.svg) | 7U5 | Name: | N-[(2R)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Formula: | C32 H28 N6 O2 | SMILES: | CCNC(=O)[CH](Cc1ccc(cc1)C#Cc2ccc3nccnc3c2)NC(=O)c4ccc5nc(C)c(C)nc5c4 | InChi: | InChI=1S/C32H28N6O2/c1-4-33-32(40)30(38-31(39)25-12-14-27-29(19-25)37-21(3)20(2)36-27)18-23-8-5-22(6-9-23)7-10-24-11-13-26-28(17-24)35-16-15-34-26/h5-6,8-9,11-17,19,30H,4,18H2,1-3H3,(H,33,40)(H,38,39)/t30-/m1/s1 | Definition date: | 2023-03-10 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | ~{N}-[(2~{R})-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide |
|
![RMF RMF](https://data.pdbj.org/pdbjplus/data/cc/svg/RMF.svg) | RMF | Name: | ~{N}-[[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]methyl]-9-(1-methylpyrazol-4-yl)-2-morpholin-4-yl-purin-6-amine | Formula: | C21 H20 Cl2 N10 O | SMILES: | Cn1cc(cn1)n2cnc3c(NCc4[nH]c5cc(Cl)c(Cl)cc5n4)nc(nc23)N6CCOCC6 | InChi: | InChI=1S/C21H20Cl2N10O/c1-31-10-12(8-26-31)33-11-25-18-19(29-21(30-20(18)33)32-2-4-34-5-3-32)24-9-17-27-15-6-13(22)14(23)7-16(15)28-17/h6-8,10-11H,2-5,9H2,1H3,(H,27,28)(H,24,29,30) | Definition date: | 2022-12-05 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | ~{N}-[[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]methyl]-9-(1-methylpyrazol-4-yl)-2-morpholin-4-yl-purin-6-amine |
|
![RP9 RP9](https://data.pdbj.org/pdbjplus/data/cc/svg/RP9.svg) | RP9 | Name: | ~{N}-(5-bromanylpyridin-2-yl)-3-(4-oxidanylidenequinazolin-3-yl)propanamide | Formula: | C16 H13 Br N4 O2 | SMILES: | Brc1ccc(NC(=O)CCN2C=Nc3ccccc3C2=O)nc1 | InChi: | InChI=1S/C16H13BrN4O2/c17-11-5-6-14(18-9-11)20-15(22)7-8-21-10-19-13-4-2-1-3-12(13)16(21)23/h1-6,9-10H,7-8H2,(H,18,20,22) | Definition date: | 2022-12-05 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | ~{N}-(5-bromanylpyridin-2-yl)-3-(4-oxidanylidenequinazolin-3-yl)propanamide |
|
![RQE RQE](https://data.pdbj.org/pdbjplus/data/cc/svg/RQE.svg) | RQE | Name: | ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-9-(1-methylpyrazol-4-yl)-2-morpholin-4-yl-purin-6-amine | Formula: | C21 H22 N10 O | SMILES: | Cn1cc(cn1)n2cnc3c(NCc4[nH]c5ccccc5n4)nc(nc23)N6CCOCC6 | InChi: | InChI=1S/C21H22N10O/c1-29-12-14(10-24-29)31-13-23-18-19(22-11-17-25-15-4-2-3-5-16(15)26-17)27-21(28-20(18)31)30-6-8-32-9-7-30/h2-5,10,12-13H,6-9,11H2,1H3,(H,25,26)(H,22,27,28) | Definition date: | 2022-12-06 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-9-(1-methylpyrazol-4-yl)-2-morpholin-4-yl-purin-6-amine |
|
![RSI RSI](https://data.pdbj.org/pdbjplus/data/cc/svg/RSI.svg) | RSI | Name: | 2-morpholin-4-yl-9-propan-2-yl-~{N}-[(4-pyridin-2-ylphenyl)methyl]purin-6-amine | Formula: | C24 H27 N7 O | SMILES: | CC(C)n1cnc2c(NCc3ccc(cc3)c4ccccn4)nc(nc12)N5CCOCC5 | InChi: | InChI=1S/C24H27N7O/c1-17(2)31-16-27-21-22(28-24(29-23(21)31)30-11-13-32-14-12-30)26-15-18-6-8-19(9-7-18)20-5-3-4-10-25-20/h3-10,16-17H,11-15H2,1-2H3,(H,26,28,29) | Definition date: | 2022-12-06 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | 2-morpholin-4-yl-9-propan-2-yl-~{N}-[(4-pyridin-2-ylphenyl)methyl]purin-6-amine |
|
![RVQ RVQ](https://data.pdbj.org/pdbjplus/data/cc/svg/RVQ.svg) | RVQ | Name: | ~{N}-[[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]methyl]-2-morpholin-4-yl-9-propan-2-yl-purin-6-amine | Formula: | C20 H22 Cl2 N8 O | SMILES: | CC(C)n1cnc2c(NCc3[nH]c4cc(Cl)c(Cl)cc4n3)nc(nc12)N5CCOCC5 | InChi: | InChI=1S/C20H22Cl2N8O/c1-11(2)30-10-24-17-18(27-20(28-19(17)30)29-3-5-31-6-4-29)23-9-16-25-14-7-12(21)13(22)8-15(14)26-16/h7-8,10-11H,3-6,9H2,1-2H3,(H,25,26)(H,23,27,28) | Definition date: | 2022-12-06 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | ~{N}-[[5,6-bis(chloranyl)-1~{H}-benzimidazol-2-yl]methyl]-2-morpholin-4-yl-9-propan-2-yl-purin-6-amine |
|
![RW6 RW6](https://data.pdbj.org/pdbjplus/data/cc/svg/RW6.svg) | RW6 | Name: | 2-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-ylmethyl)-6,7-dimethoxy-3~{H}-quinazolin-4-one | Formula: | C18 H19 N3 O3 S | SMILES: | COc1cc2N=C(CN3CCc4sccc4C3)NC(=O)c2cc1OC | InChi: | InChI=1S/C18H19N3O3S/c1-23-14-7-12-13(8-15(14)24-2)19-17(20-18(12)22)10-21-5-3-16-11(9-21)4-6-25-16/h4,6-8H,3,5,9-10H2,1-2H3,(H,19,20,22) | Definition date: | 2022-12-07 | Last modified: | 2023-09-08 | Release date: | 2023-09-13 | Identifier: | 2-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-ylmethyl)-6,7-dimethoxy-3~{H}-quinazolin-4-one |
|
![SKI SKI](https://data.pdbj.org/pdbjplus/data/cc/svg/SKI.svg) | SKI | Name: | 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine | Formula: | C22 H19 N3 O3 | SMILES: | COc1cc2c(cc1OC)ncnc2Nc1ccc(Oc2ccccc2)cc1 | InChi: | InChI=1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25) | Definition date: | 2021-03-04 | Last modified: | 2023-09-01 | Release date: | 2023-09-06 | Identifier: | 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine |
|
![L2V L2V](https://data.pdbj.org/pdbjplus/data/cc/svg/L2V.svg) | L2V | Name: | N-[(2R)-1-(ethylamino)-1-oxidanylidene-3-[3-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Formula: | C32 H28 N6 O2 | SMILES: | CCNC(=O)[CH](Cc1cccc(c1)C#Cc2ccc3nccnc3c2)NC(=O)c4ccc5nc(C)c(C)nc5c4 | InChi: | InChI=1S/C32H28N6O2/c1-4-33-32(40)30(38-31(39)25-11-13-27-29(19-25)37-21(3)20(2)36-27)18-24-7-5-6-22(16-24)8-9-23-10-12-26-28(17-23)35-15-14-34-26/h5-7,10-17,19,30H,4,18H2,1-3H3,(H,33,40)(H,38,39)/t30-/m1/s1 | Definition date: | 2023-08-21 | Last modified: | 2023-09-01 | Release date: | 2023-09-06 | Identifier: | ~{N}-[(2~{R})-1-(ethylamino)-1-oxidanylidene-3-[3-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide |
|
![O6X O6X](https://data.pdbj.org/pdbjplus/data/cc/svg/O6X.svg) | O6X | Name: | ~{N}-[6-methoxy-2-(2-morpholin-4-yl-2-oxidanylidene-ethyl)indazol-5-yl]-6-[(1~{R})-2,2,2-tris(fluoranyl)-1-oxidanyl-ethyl]pyridine-2-carboxamide | Formula: | C22 H22 F3 N5 O5 | SMILES: | COc1cc2nn(CC(=O)N3CCOCC3)cc2cc1NC(=O)c4cccc(n4)[CH](O)C(F)(F)F | InChi: | InChI=1S/C22H22F3N5O5/c1-34-18-10-16-13(11-30(28-16)12-19(31)29-5-7-35-8-6-29)9-17(18)27-21(33)15-4-2-3-14(26-15)20(32)22(23,24)25/h2-4,9-11,20,32H,5-8,12H2,1H3,(H,27,33)/t20-/m1/s1 | Definition date: | 2022-08-30 | Last modified: | 2023-09-01 | Release date: | 2023-09-06 | Identifier: | ~{N}-[6-methoxy-2-(2-morpholin-4-yl-2-oxidanylidene-ethyl)indazol-5-yl]-6-[(1~{R})-2,2,2-tris(fluoranyl)-1-oxidanyl-ethyl]pyridine-2-carboxamide |
|
![UM6 UM6](https://data.pdbj.org/pdbjplus/data/cc/svg/UM6.svg) | UM6 | Name: | 7-chloranyl-4-[(3R)-3-fluoranylpyrrolidin-1-yl]-1-phenyl-quinazolin-2-one | Formula: | C18 H15 Cl F N3 O | SMILES: | F[CH]1CCN(C1)C2=NC(=O)N(c3ccccc3)c4cc(Cl)ccc24 | InChi: | InChI=1S/C18H15ClFN3O/c19-12-6-7-15-16(10-12)23(14-4-2-1-3-5-14)18(24)21-17(15)22-9-8-13(20)11-22/h1-7,10,13H,8-9,11H2/t13-/m1/s1 | Definition date: | 2023-02-07 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | 7-chloranyl-4-[(3~{R})-3-fluoranylpyrrolidin-1-yl]-1-phenyl-quinazolin-2-one |
|
![WZK WZK](https://data.pdbj.org/pdbjplus/data/cc/svg/WZK.svg) | WZK | Name: | N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(5-hydroxyisoquinolin-4-yl)acetamide | Formula: | C24 H22 Cl N3 O2 S | SMILES: | Clc1cc(CN(C(=O)Cc2cncc3cccc(O)c32)c2ccc(cc2)N(C)C)sc1 | InChi: | InChI=1S/C24H22ClN3O2S/c1-27(2)19-6-8-20(9-7-19)28(14-21-11-18(25)15-31-21)23(30)10-17-13-26-12-16-4-3-5-22(29)24(16)17/h3-9,11-13,15,29H,10,14H2,1-2H3 | Definition date: | 2023-05-24 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(5-hydroxyisoquinolin-4-yl)acetamide |
|
![WIV WIV](https://data.pdbj.org/pdbjplus/data/cc/svg/WIV.svg) | WIV | Name: | 6-cyclopropyl-~{N}-(2-methylindazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide | Formula: | C21 H22 N6 O | SMILES: | CC(C)n1ncc2c1nc(cc2C(=O)Nc3ccc4nn(C)cc4c3)C5CC5 | InChi: | InChI=1S/C21H22N6O/c1-12(2)27-20-17(10-22-27)16(9-19(24-20)13-4-5-13)21(28)23-15-6-7-18-14(8-15)11-26(3)25-18/h6-13H,4-5H2,1-3H3,(H,23,28) | Definition date: | 2023-05-15 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | 6-cyclopropyl-~{N}-(2-methylindazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-b]pyridine-4-carboxamide |
|
![6I9 6I9](https://data.pdbj.org/pdbjplus/data/cc/svg/6I9.svg) | 6I9 | Name: | N-[4-(azetidin-1-yl)-2-(4-methylphenyl)quinolin-6-yl]-2-methylpropanamide | Formula: | C23 H25 N3 O | SMILES: | CC(C)C(=O)Nc1cc2c(nc(cc2N2CCC2)c2ccc(C)cc2)cc1 | InChi: | InChI=1S/C23H25N3O/c1-15(2)23(27)24-18-9-10-20-19(13-18)22(26-11-4-12-26)14-21(25-20)17-7-5-16(3)6-8-17/h5-10,13-15H,4,11-12H2,1-3H3,(H,24,27) | Definition date: | 2023-04-20 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | N-[4-(azetidin-1-yl)-2-(4-methylphenyl)quinolin-6-yl]-2-methylpropanamide |
|
![P5X P5X](https://data.pdbj.org/pdbjplus/data/cc/svg/P5X.svg) | P5X | Name: | N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(isoquinolin-4-yl)acetamide | Formula: | C24 H22 Cl N3 O S | SMILES: | Clc1cc(CN(C(=O)Cc2cncc3ccccc32)c2ccc(cc2)N(C)C)sc1 | InChi: | InChI=1S/C24H22ClN3OS/c1-27(2)20-7-9-21(10-8-20)28(15-22-12-19(25)16-30-22)24(29)11-18-14-26-13-17-5-3-4-6-23(17)18/h3-10,12-14,16H,11,15H2,1-2H3 | Definition date: | 2022-05-25 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | N-[(4-chlorothiophen-2-yl)methyl]-N-[4-(dimethylamino)phenyl]-2-(isoquinolin-4-yl)acetamide |
|
![P6I P6I](https://data.pdbj.org/pdbjplus/data/cc/svg/P6I.svg) | P6I | Name: | N-[(4-chlorothiophen-2-yl)methyl]-2-(isoquinolin-4-yl)-N-[4-(methylsulfanyl)phenyl]acetamide | Formula: | C23 H19 Cl N2 O S2 | SMILES: | Clc1cc(CN(C(=O)Cc2cncc3ccccc32)c2ccc(SC)cc2)sc1 | InChi: | InChI=1S/C23H19ClN2OS2/c1-28-20-8-6-19(7-9-20)26(14-21-11-18(24)15-29-21)23(27)10-17-13-25-12-16-4-2-3-5-22(16)17/h2-9,11-13,15H,10,14H2,1H3 | Definition date: | 2022-05-25 | Last modified: | 2023-08-25 | Release date: | 2023-08-30 | Identifier: | N-[(4-chlorothiophen-2-yl)methyl]-2-(isoquinolin-4-yl)-N-[4-(methylsulfanyl)phenyl]acetamide |
|